Table 4 |
||||||
|
Expression of CX3CL1 and CX3CR1 in the lung tissue from each of the patients |
||||||
|
Polymyositis |
Dermatomyositis |
|||||
|
|
||||||
|
Pt1 |
Pt2 |
Pt3 |
Pt1 |
Pt2 |
Pt3 |
|
|
|
||||||
|
CX3CL1 |
||||||
|
Infiltrated mononuclear cells |
50.8 |
20.6 |
12.1 |
42.3 |
19.8 |
13.9 |
|
Alveolar macrophages |
79.6 |
71.1 |
58.3 |
78.1 |
53.4 |
78.6 |
|
Epithelial cells |
59.5 |
34.6 |
53.9 |
48.3 |
31.3 |
45.3 |
|
Endothelial cells |
22.1 |
23.6 |
17.0 |
17.9 |
13.8 |
9.4 |
|
CX3CR1 |
||||||
|
Infiltrated mononuclear cells |
31.8 |
20.8 |
23.4 |
33.0 |
21.1 |
44.2 |
|
Alveolar macrophages |
77.0 |
70.4 |
47.0 |
73.0 |
54.1 |
68.2 |
|
Epithelial cells |
49.5 |
72.6 |
59.8 |
76.5 |
39.6 |
38.9 |
|
|
||||||
|
Percentage frequency of CX3CL1 and CX3CR1 expression in each cell type in each of the patients. |
||||||
|
Suzuki et al. Arthritis Research & Therapy 2012 14:R48 doi:10.1186/ar3761 |
||||||
